Skip to content
Peptide History intermediate

## Key Trends 1. **From Discovery to Therapy**: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+) 2. **Technology Drivers**: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design 3. **Therapeutic Evolution**: Single targets → combination therapies → multi-target agonists 4. **Acceleration Pattern**: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs ## Category Definitions

Description

By Encyclopeptide Editorial | 3 min read
peptide-history peptide oligopeptide

Overview

  1. From Discovery to Therapy: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+)

  2. Technology Drivers: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design

  3. Therapeutic Evolution: Single targets → combination therapies → multi-target agonists

  4. Acceleration Pattern: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs

Category Definitions is a peptide compound with applications in research and therapeutics. Description

Chemical Identity

PropertyValue
Name## Key Trends
  1. From Discovery to Therapy: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+)

  2. Technology Drivers: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design

  3. Therapeutic Evolution: Single targets → combination therapies → multi-target agonists

  4. Acceleration Pattern: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs

Category Definitions |

| Sequence | Category | | Length | 8 amino acids |

| Category | Peptide History |

Structure

  1. From Discovery to Therapy: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+)

  2. Technology Drivers: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design

  3. Therapeutic Evolution: Single targets → combination therapies → multi-target agonists

  4. Acceleration Pattern: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs

Category Definitions belongs to the Peptide History class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.

Applications

  1. From Discovery to Therapy: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+)

  2. Technology Drivers: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design

  3. Therapeutic Evolution: Single targets → combination therapies → multi-target agonists

  4. Acceleration Pattern: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs

Category Definitions has been studied for its potential applications in:

  • Biomedical research
  • Drug discovery
  • Diagnostic applications
  • Therapeutic development

References

  • Source: peptide-history.md
  • Database: Wikipept Peptide Database

Test Your Knowledge

Reinforce what you learned about ## Key Trends 1. **From Discovery to Therapy**: Amino acid discovery (1820) → peptide hormones (1920s) → synthetic peptides (1950s) → recombinant proteins (1980s) → peptide drugs (2000s+) 2. **Technology Drivers**: X-ray crystallography, DNA sequencing, recombinant DNA, solid-phase synthesis, computational design 3. **Therapeutic Evolution**: Single targets → combination therapies → multi-target agonists 4. **Acceleration Pattern**: ~80 years between first amino acid and first recombinant protein; ~20 years between GLP-1 discovery and blockbuster obesity drugs ## Category Definitions with interactive quizzes on Wikipept.

Take a Quiz on Wikipept